Welcome
FDA may have known about Avandia and heart problems in ’02
May 22nd, 2007
The watchdog group Public Citizen is saying that as early as 2002, the Food and Drug Administration realized that people taking Avandia, GlaxoSmithKline’s popular diabetes drug, were at a serious risk of heart attack. FDA staff scientists then were saying…more »
NEJM editorial supports Dr. Nissen’s Avandia conclusions
May 21st, 2007
The New England Journal of Medicine recently featured an article, written by Dr. Steven Nissen, about the diabetes drug Avandia. Its conclusions, about side effects such as heart problems and heart attacks, were worrisome enough to merit an accompanying editorial.…more »
Dr. Nissen’s study shows similarities of Vioxx and Avandia
May 21st, 2007
The heart risks of Merck’s painkiller Vioxx led to a crisis for the drugmaker four years ago. The drug was withdrawn, the company’s CEO later resigned, lawsuits proliferated, and the Food and Drug Administration was subjected to much criticism for…more »
Avandia’s label gets tougher warning
April 29th, 2002
The diabetes drug Avandia has been linked with weight gain and fluid retention, both of which can lead to or aggravate congestive heart failure, according to the Food and Drug Administration. GlaxoSmithKline makes and sells Avandia for the treatment of…more »